Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village

Gaudart, Jean; Poudiougou, Belco; Dicko, Alassane; Ranque, Stéphane; Toure, Ousmane; Sagara, Issaka; Diallo, Mouctar; Diawara, Sory; Ouattara, Amed; Diakite, Mahamadou; Doumbo, Ogobara K.
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p286
Academic Journal
Background: Spatial and temporal heterogeneities in the risk of malaria have led the WHO to recommend fine-scale stratification of the epidemiological situation, making it possible to set up actions and clinical or basic researches targeting high-risk zones. Before initiating such studies it is necessary to define local patterns of malaria transmission and infection (in time and in space) in order to facilitate selection of the appropriate study population and the intervention allocation. The aim of this study was to identify, spatially and temporally, high-risk zones of malaria, at the household level (resolution of 1 to 3 m). Methods: This study took place in a Malian village with hyperendemic seasonal transmission as part of Mali-Tulane Tropical Medicine Research Center (NIAID/NIH). The study design was a dynamic cohort (22 surveys, from June 1996 to June 2001) on about 1300 children (<12 years) distributed between 173 households localized by GPS. We used the computed parasitological data to analyzed levels of Plasmodium falciparum, P. malariae and P. ovale infection and P. falciparum gametocyte carriage by means of time series and Kulldorff's scan statistic for space-time cluster detection. Results: The time series analysis determined that malaria parasitemia (primarily P. falciparum) was persistently present throughout the population with the expected seasonal variability pattern and a downward temporal trend. We identified six high-risk clusters of P. falciparum infection, some of which persisted despite an overall tendency towards a decrease in risk. The first high-risk cluster of P. falciparum infection (rate ratio = 14.161) was detected from September 1996 to October 1996, in the north of the village. Conclusion: This study showed that, although infection proportions tended to decrease, high-risk zones persisted in the village particularly near temporal backwaters. Analysis of this heterogeneity at the household scale by GIS methods lead to target preventive actions more accurately on the high-risk zones identified. This mapping of malaria risk makes it possible to orient control programs, treating the high-risk zones identified as a matter of priority, and to improve the planning of intervention trials or research studies on malaria.


Related Articles

  • Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Schultz, Lee; Wapling, Johanna; Mueller, Ivo; Ntsuke, Pilate O.; Senn, Nicolas; Nale, Joe; Kiniboro, Benson; Buckee, Caroline O.; Tavul, Livingstone; Siba, Peter M.; Reeder, John C.; Barry, Alyssa E. // Malaria Journal;2010, Vol. 9, p336 

    Background: The South West Pacific nation of Papua New Guinea has intense year round transmission of Plasmodium falciparum on the coast and in the low-lying inland areas. Local heterogeneity in the epidemiology of malaria suggests that parasites from multiple locations will need to be surveyed...

  • NEW MALARIA VACCINES ROADMAP TARGETS NEXT GENERATION PRODUCTS BY 2030.  // Central European Journal of Public Health;Dec2013, Vol. 21 Issue 4, p206 

    The article discusses the 2013 Malaria Vaccine Technology Roadmap that was launched on November 14. The Roadmap aims to have vaccines that can reduce malaria cases by 75% and eliminate malaria licensed by 2030, in addition to the original 2006 Roadmap's goal of having a licensed vaccine against...

  • A Vaccine for Malaria. White, Nicholas J. // New England Journal of Medicine;11/17/2011, Vol. 365 Issue 20, p1926 

    The article discusses the development of the Plasmodium falciparum malaria vaccine in 2011, which should be available in just over three years. It says that the World Health Organization (WHO) has indicated the possibility of recommending the first malaria vaccine for use in Africa as early as...

  • Ready-to-Use Therapeutic Food for Catch-Up Growth in Children after an Episode of Plasmodium falciparum Malaria: An Open Randomised Controlled Trial. van der Kam, Saskia; Swarthout, Todd; Niragira, Oscar; Froud, Alyson; Sompwe, Eric Mukomena; Mills, Clair; Roll, Stephanie; Tinnemann, Peter; Shanks, Leslie // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Catch-up growth after an infection is essential for children to maintain good nutritional status. To prevent malnutrition, WHO recommends that children are given one additional healthy meal per day during the 2 weeks after onset of illness. We investigated to what extent ready-to-use...

  • Pharmacokinetics and Comparative Bioavailability of Artesunate and Mefl oquine Administered Separately or as a Fixed Combination Product to Healthy Volunteers and Patients with Uncomplicated Plasmodium falciparum Malaria. Olliaro, Piero; Ramanathan, Surash; Vaillant, Michel; Reuter, Stephanie E.; Evans, Allan M.; Krudsood, Srivicha; Looareesuwan, Sornchai; Kiechel, Jean-René; Taylor, Walter R. J.; Navaratnam, Visweswaran // Journal of Bioequivalence & Bioavailability;2010, Vol. 2 Issue 3, p59 

    Purpose: The current World Health Organization recommendation for the treatment of uncomplicated Plasmodium falciparum malaria is with artemisinin-based combination therapy. Artesunate and mefloquine combination therapy has achieved consistently high efficacy rates and reduced malaria morbidity;...

  • Paludismo grave en un militar en activo. Kaneko-Wada, Francisco Takao; Muñoz-Monroy, Omar Eloy; Díaz, Sergio Hernández; Del Ángel-Guevara, Óscar; Salgado-Camarillo, Javier; Pescina-Casas, Juan // Revista de Sanidad Militar;sep/oct2008, Vol. 62 Issue 5, p241 

    Malaria should be considered a medical emergency due to its rapid progression and development of complications occasionally lethal. Malaria continues as a public health problem in Mexico where vector control has not been completely successful. Severe malaria is associated with Plasmodium...

  • The clinical efficacy of artemether/lumefantrine (Coartem). Makanga, Michael; Krudsood, Srivicha // Malaria Journal;2009 Supplement 1, Vol. 8, p1 

    Current World Health Organization (WHO) guidelines for the treatment of uncomplicated falciparum malaria recommend the use of artemisinin-based combination therapy (ACT). Artemether/ lumefantrine is an ACT prequalified by the WHO for efficacy, safety and quality, approved by Swissmedic in...

  • New WHO guidelines for the treatment of malaria. Reyburn, Hugh // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/24/2010, Vol. 341 Issue 7765, p161 

    The author reflects on the publication of the second edition of the guidelines by the World Health Organization (WHO) in the treatment of malaria. He states that the guidelines contain a detailed account for the treatment of malaria caused by Plasmodium falciparum. He highlights the combination...

  • Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.  // Malaria Journal;2011, Vol. 10 Issue 1, p293 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics